Telehealth Treatment for Alcohol Use Disorder

Trial ID or NCT#

NCT05747703

Status

recruiting iconRECRUITING

Purpose

Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.

Official Title

A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * alcohol use disorder
Exclusion Criteria:
  1. * inability to provide informed consent
View All Criteria
Show Less

Investigator(s)

Judith Prochaska
Senior Associate Vice Provost, Clinical Research Governance and Professor of Medicine (Stanford Prevention Research Center)
Allison Kwong
Allison Kwong
Hepatologist, Transplant hepatologist
Assistant Professor of Medicine (Gastroenterology and Hepatology)

Contact us to find out if this trial is right for you.

Contact

Amy Chieng
415-216-5853

SEND MESSAGE

View on ClinicalTrials.gov